Home
Categories
DMD
Research
Family Stories
Approved Treatments
Cures
About Us
Contact
Search
Home
Categories
DMD
Research
Family Stories
Approved Treatments
Cures
About Us
Contact
More
Search
Home
Tags
Sarepta
Sarepta
DMD
Brazilian Children Over 7 and Their Families Demand Elevidys Gene Therapy from Anvisa
DMD
Will Elevidys Receive Approval from the European Medicines Agency (EMA)?
Research
Roche Announces New Results from the EMBARK Study of Elevidys in Outpatients with Duchenne Muscular Dystrophy (DMD)
Family Stories
South Korean Trending News: Father Walks 740 km for Daughter with Duchenne Muscular Dystrophy
DMD
Elevidys Gene Therapy has Arrived in Brazil and Could Cost up to 20 Million Brazilian Reais
DMD
3 Drugs Receiving Accelerated Approval from the FDA and Reviewed by the Office of Inspector General Raised Concerns
DMD
Sarepta Reiterated Total Net Product Revenue of $3.0 Billion in 2025
DMD
Turkish DMD Patients Who are Eligible for Exon 51 Skipping Treatment (Eteplirsen) Request Their Medications from the Ministry of Health
Approved Treatments
Frequently Asked Questions About Eteplirsen (Exondys 51) for DMD Treatment
1
2
Page 1 of 2
Categories
Research
39
DMD
37
Approved Treatments
7
Family Stories
3
Must Read
Research
Insmed’s Gene Therapy (INS1201) Poised to Challenge Duchenne Muscular Dystrophy (DMD)
Research
Solid Biosciences Releases Information on Clinical Trial for SGT-003 Gene Therapy
Approved Treatments
NICE Final Guidance for AGAMREE (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy Is Positive for Santhera